Home > News > pSivida gets new European Patents for BioSilicon
March 15th, 2004
pSivida gets new European Patents for BioSilicon
Abstract:
Global nanotechnology company pSivida Limited (PSD) announced today that it’s UK operating subsidiary pSiMedica has been granted a further patent in the European market. Managing director Gavin Rezos said this new European Patent is another important addition to an already strong Intellectual Property portfolio. “This also follows the recent patent granted in the US for potential ‘smart’ drug delivery applications of BioSilicon.”
Source:
egoli
Bookmark:
| Related News Press |
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||